SRTS stock: buy or sell?

SRTS stock price: $3.51 -0.85% At close on November 15th, 2019

Updated on:
November 15th, 2019


After sliding a bloodcurdling -7.06% on November/14, Sensus Healthcare closed yesterday at $3.51 and depreciated a disappointing -0.85%.

Sensus Healthcare, Inc. manufactures and markets superficial radiation therapy devices to healthcare providers worldwide.

Should I buy SRTS stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

Currently, Sensus Healthcare stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Sensus Healthcare stock a buy?

Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness. At, we found 1 rating published for SRTS stock in the last 30 days.

Is SRTS a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-2-15Northland Securitiesn/aSell

SRTS stock analysis

Daily outlook

After sliding a bloodcurdling -7.06% on Nov/14, Sensus Healthcare closed yesterday at $3.51 and depreciated a disappointing -0.85%.

After sliding a bloodcurdling -7.06% on Nov/14, Sensus Healthcare closed yesterday at $3.51 and depreciated a disappointing -0.85%.

SRTS stock chart (daily)

Weekly outlook

Sensus Healthcare shares plunged -7.63% this week, ending at $3.51.

Far behind is the all-time high Sensus Healthcare recorded by mid March and since then the price is -61.97% below that top. Since price and 40-weeks moving average lines crossed down late March, SRTS fell $-3.84 per share (-52.24%). Stocks below the 40w moving average line are usually not recommended for average traders.

SRTS stock chart (weekly)

SRTS stock price history

SRTS stock went public on July 28th, 2016 with a price of $6.501. Since then, SRTS stock sliced a -46.00%, with a yearly average of -15.30%.

1: Adjusted price after possible price splits or reverse-splits.

SRTS stock historical price chart

SRTS stock reached all-time highs on March with a price of $9.23.

SRTS stock price target is $5.00

Nobody can reliably foresee how stock prices may evolve in the future. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last 30 days we only found 1 price target for Sensus Healthcare stock:
SRTS stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-2-15Northland SecuritiesReiteratesn/a$5.00-
(in average)$0.00$5.000.0%

Financials and fundamental analysis

Earnings date and Earnings per Share

Since February, when Sensus Healthcare posted its last earnings report, it . Unfortunately, reported EPS is not yet available in our database.
SRTS earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

In 2018, Sensus Healthcare annual turnover rocketed a dazzling 28.36% to $26.43 M dollars from $20.59 marked in 2017. When comparing 2018 vs 2017, in the same way, profit margin (that is, the net income divided by revenues) climbed a 10.37% to -7.65%.

SRTS annual Sales and Income evolution
2013$10 M-$0.11 M1.0%-
2014$5.81 M-44.56%$-3.70 M-63.7%-3,537.31%
2015$10 M76.81%$-0.24 M-2.3%-93.59%
2016$15 M44.17%$-0.35 M-2.3%46.02%
2017$21 M39.00%$-3.71 M-18.0%971.01%
2018$26 M28.36%$-2.02 M-7.7%-45.49%

Quarterly financial results

Sensus Healthcare posted $8.08 M in revenues for 2018-Q4, a 27.58% improvement compared to previous quarter. Reported quarter income marked $0.10 M with a profit margin of 1.26%. Profit margin soared a 8.49% compared to previous quarter when profit margin was -7.23%. When comparing sales to same quarter last year, Sensus Healthcare sales marked an exceptional gain and skyrocketed a 24.91%. Looking back to recent quarterly results, Sensus Healthcare posted 3 positive quarters in a row.
SRTS quarterly Sales and Income evolution
2017-Q1$4 M-$-1.57 M-36.1%-
2017-Q2$5 M14.25%$-0.76 M-15.4%-51.33%
2017-Q3$5 M-3.51%$-0.97 M-20.1%26.38%
2017-Q4$6 M34.91%$-0.41 M-6.3%-57.69%
2018-Q1$6 M-7.95%$-1.13 M-18.9%175.56%
2018-Q2$6 M1.70%$-0.54 M-8.9%-51.98%
2018-Q3$6 M4.58%$-0.46 M-7.2%-15.27%
2018-Q4$8 M27.58%$0.10 M1.3%-122.25%

Sensus Healthcare ownership

When you are planning to buy a stock, it's always worth to review its ownership structure.

Sensus Healthcare shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 32.86% of all shares.

In case of Sensus Healthcare stock, 8.38% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for SRTS stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Sensus Healthcare:

Market cap$57.9 M$397.8 M
Total shares16.5 M49.3 M
Float shares11.4 M38.1 M
  - Institutional holdings (%)8.4%93.3%
  - Insider holdings (%)32.9%1.7%
Shares in short selling0.0%0.0%

SRTS summary

Friday, November 15th, 2019
Day range$3.47 - $3.63
Previous close$3.54
Session gain-0.85%
Average true range$0.32
50d mov avg$5.59
100d mov avg$5.63
200d mov avg$6.10
Daily patternlt01c
Weekly pattern lt03c

Sensus Healthcare performance

To measure stock performance is always good to benchmark with competitors or related stocks. We picked Array as the bechmarking frame for Sensus Healthcare stock.
SRTSSensus Healthcare-44.81%-36.53%-40.00%

Sensus Healthcare competitors

Defining a list of competitors for Sensus Healthcare it's tough. We selected just one public company that in our opinion is related to and can be considered Sensus Healthcare competitor: